Journal article
Outcome of Transfusion of K:11 Erythrocytes in a Patient with Anti‐K11 Antibody
Vox sanguinis, Vol.74(3), pp.205-208
04/1998
DOI: 10.1046/j.1423-0410.1998.7430205.x
PMID: 9595651
Abstract
Background and objectives: The clinical significance of anti‐K11 in red cell transfusion therapy is unknown. We report the outcome of transfusion of K:11 erythrocytes into a patient with a known anti‐K11 antibody. Materials and methods: The patient was monitored clinically following transfusion of 11 units of K: 11 erythrocytes. A red cell survival study with K: 11 erythrocytes and a monocyte monolayer assay (MMA) were performed. Results: No adverse clinical outcome was detected. The red cell survival study showed normal survival of K: 11 erythrocytes, and the MMA showed no increase in reactive monocytes. Conclusion: These findings suggest that K:11 red cells can safely be transfused to individuals with anti‐K11 antibody.
Details
- Title: Subtitle
- Outcome of Transfusion of K:11 Erythrocytes in a Patient with Anti‐K11 Antibody
- Creators
- Carolyn M KelleyMark W KarwalAnnette J SchlueterJohn D Olson
- Resource Type
- Journal article
- Publication Details
- Vox sanguinis, Vol.74(3), pp.205-208
- Publisher
- Blackwell Science Ltd; Oxford, UK
- DOI
- 10.1046/j.1423-0410.1998.7430205.x
- PMID
- 9595651
- ISSN
- 0042-9007
- eISSN
- 1423-0410
- Number of pages
- 4
- Language
- English
- Date published
- 04/1998
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Pathology; Internal Medicine
- Record Identifier
- 9984047643302771
Metrics
10 Record Views